ProPhase Labs Inc(PRPH)
10.16
Change: 0 (0)
As of Tue 12/20/2022 01:22 PM% Of Value
Growth
Value Per Share
:
:
:
-603.45
444.59
3.7200 (as of 19/12/2022)
Fundamentals Data
| Open | 10.04 | Dividend | 17 |
| Close Price | 10.16 | DivYield | 0 % |
| High | 10.4 | Growth | 64.5 M |
| Low | 10 | Growth% | 444.59 |
| P/e | -21.519 | Volume | 57,907.0 |
| P/b | -0.18 | Market Capital | 153.9 M |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 10.91 (as of 20/12/2022) | 50 Days Moving Average Percentage | -7.2180746561886 (as of 20/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 9.8 M | 13.1 M | 9.8 M | 14.5 M | 79.0 M |
| Cap Spending | -208,000.0 | -140,000.0 | -228,000.0 | 392,000.0 | -4.2 M |
| Operating Expenses | 5.9 M | 6.4 M | 5.8 M | 8.5 M | 32.1 M |
| Operating Cash Flow | -3.9 M | -1.6 M | -3.2 M | -3.9 M | 9.8 M |
| Free Cash Flow | -3.0 M | -2.2 M | -1.0 M | -2.2 M | -17.8 M |
| Free Cash Flow Per Share | -0.196 | -0.198 | -0.092 | -0.19 | -1.177 |
| Total liabilities | 0.0 | 0.0 | 0.0 | 14.7 M | 14.9 M |
| Total cash | 3.1 M | 1.5 M | 434,000.0 | 6.8 M | 8.6 M |
| ROE% | 1.002 | -0.077 | -0.225 | -0.198 | 0.121 |
| Outstanding Shares | 11.1 M | 11.5 M | 11.5 M | 15.1 M | 15.4 M |
| P/E | 0.785 | -21.519 | -6.443 | -52.737 | 17.281 |
| P/S | 3.327 | 2.853 | 2.052 | 7.721 | 1.371 |
| Revenue USD | 9.8 M | 13.1 M | 9.8 M | 14.5 M | 79.0 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|